Literature DB >> 91079

[Present state of resistance to antibiotics by tuberculous bacilli in Africa (author's transl)].

J L Rey, A Villon, M Menard, G Le Mao, J P Albert.   

Abstract

Tuberculous bacilli isolated from recently infected patients from various african countries, are resistant to the main specific antibiotics. The present study analyses these resistances which are frequent and mainly directed against INH and streptomycin. Resistance against INH is frequently associated, and is due to inadequate monitoring of the treatment. The resistance against streptomycin is probably due in part to the frequent use of streptomycin against common non-tuberculous infections. The high frequency of thiacetazone resistance is associated with the geographical distribution of M. africanum. Given the situation, it is necessary to consider discarding this drug and replacing it. Unfortunately however, the most recent antibiotics, which have not yet generated resistant strains, are often too expensive.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 91079      PMCID: PMC8331894     

Source DB:  PubMed          Journal:  Med Trop (Mars)        ISSN: 0025-682X


  3 in total

1.  First molecular epidemiology study of Mycobacterium tuberculosis in Burkina Faso.

Authors:  S Godreuil; G Torrea; D Terru; F Chevenet; S Diagbouga; P Supply; P Van de Perre; C Carriere; A L Bañuls
Journal:  J Clin Microbiol       Date:  2007-01-24       Impact factor: 5.948

Review 2.  Mycobacterium africanum--review of an important cause of human tuberculosis in West Africa.

Authors:  Bouke C de Jong; Martin Antonio; Sebastien Gagneux
Journal:  PLoS Negl Trop Dis       Date:  2010-09-28

3.  The Guinea-Bissau family of Mycobacterium tuberculosis complex revisited.

Authors:  Ramona Groenheit; Solomon Ghebremichael; Jenny Svensson; Paulo Rabna; Raffaella Colombatti; Fabio Riccardi; David Couvin; Véronique Hill; Nalin Rastogi; Tuija Koivula; Gunilla Källenius
Journal:  PLoS One       Date:  2011-04-20       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.